{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T02:27:33Z","timestamp":1778898453129,"version":"3.51.4"},"reference-count":28,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2024,2,20]],"date-time":"2024-02-20T00:00:00Z","timestamp":1708387200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Ministry of Health, Labour, and Welfare of Japan","award":["H29-Sukoyaka\u2013Shitei-001"],"award-info":[{"award-number":["H29-Sukoyaka\u2013Shitei-001"]}]},{"name":"Ministry of Health, Labour, and Welfare of Japan","award":["23FC1033"],"award-info":[{"award-number":["23FC1033"]}]},{"name":"Ministry of Health, Labour, and Welfare of Japan","award":["JP20ek0109482"],"award-info":[{"award-number":["JP20ek0109482"]}]},{"name":"Ministry of Health, Labour, and Welfare of Japan","award":["JP23ek0109636"],"award-info":[{"award-number":["JP23ek0109636"]}]},{"name":"Japan Agency for Medical Research and Development","award":["H29-Sukoyaka\u2013Shitei-001"],"award-info":[{"award-number":["H29-Sukoyaka\u2013Shitei-001"]}]},{"name":"Japan Agency for Medical Research and Development","award":["23FC1033"],"award-info":[{"award-number":["23FC1033"]}]},{"name":"Japan Agency for Medical Research and Development","award":["JP20ek0109482"],"award-info":[{"award-number":["JP20ek0109482"]}]},{"name":"Japan Agency for Medical Research and Development","award":["JP23ek0109636"],"award-info":[{"award-number":["JP23ek0109636"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJNS"],"abstract":"<jats:p>Very-long-chain acyl-CoA dehydrogenase (VLCAD) deficiency is a long-chain fatty acid oxidation disorder that manifests as either a severe phenotype associated with cardiomyopathy, a hypoglycemic phenotype, or a myopathic phenotype. As the hypoglycemic phenotype can cause sudden infant death, VLCAD deficiency is included in newborn screening (NBS) panels in many countries. The tetradecenoylcarnitine (C14:1) level in dried blood specimens is commonly used as a primary marker for VLCAD deficiency in NBS panels. Its ratio to acetylcarnitine (C2) and various other acylcarnitines is used as secondary markers. In Japan, tandem mass spectrometry-based NBS, initially launched as a pilot study in 1997, was introduced to the nationwide NBS program in 2013. In the present study, we evaluated levels of acylcarnitine with various chain lengths (C18 to C2), free carnitine, and their ratios in 175 infants who tested positive for VLCAD deficiency with C14:1 and C14:1\/C2 ratios. Our analyses indicated that the ratios of C14:1 to medium-chain acylcarnitines (C10, C8, and C6) were the most effective markers in reducing false-positive rates. Their use with appropriate cutoffs is expected to improve NBS performance for VLCAD deficiency.<\/jats:p>","DOI":"10.3390\/ijns10010015","type":"journal-article","created":{"date-parts":[[2024,2,20]],"date-time":"2024-02-20T11:50:07Z","timestamp":1708429807000},"page":"15","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Using the C14:1\/Medium-Chain Acylcarnitine Ratio Instead of C14:1 to Reduce False-Positive Results for Very-Long-Chain Acyl-CoA Dehydrogenase Deficiency in Newborn Screening in Japan"],"prefix":"10.3390","volume":"10","author":[{"given":"Go","family":"Tajima","sequence":"first","affiliation":[{"name":"Division of Neonatal Screening, Research Institute, National Center for Child Health and Development, 2-10-1 Okura, Setagaya-ku, Tokyo 157-8535, Japan"},{"name":"Department of Pediatrics, Hiroshima University Graduate School of Biomedical and Health Sciences, 1-2-3 Kasumi, Minami-ku, Hiroshima 734-8551, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junko","family":"Aisaki","sequence":"additional","affiliation":[{"name":"Division of Neonatal Screening, Research Institute, National Center for Child Health and Development, 2-10-1 Okura, Setagaya-ku, Tokyo 157-8535, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiichi","family":"Hara","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Hiroshima University Graduate School of Biomedical and Health Sciences, 1-2-3 Kasumi, Minami-ku, Hiroshima 734-8551, Japan"},{"name":"Department of Pediatrics, National Hospital Organization Kure Medical Center and Chugoku Cancer Center, 3-1 Aoyama-cho, Kure 737-0023, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miyuki","family":"Tsumura","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Hiroshima University Graduate School of Biomedical and Health Sciences, 1-2-3 Kasumi, Minami-ku, Hiroshima 734-8551, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reiko","family":"Kagawa","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Hiroshima University Graduate School of Biomedical and Health Sciences, 1-2-3 Kasumi, Minami-ku, Hiroshima 734-8551, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumiaki","family":"Sakura","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Hiroshima University Graduate School of Biomedical and Health Sciences, 1-2-3 Kasumi, Minami-ku, Hiroshima 734-8551, Japan"},{"name":"Department of Technology Development, Kazusa DNA Research Institute, 2-6-7 Kazusa-kamatari, Kisarazu 292-0818, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7704-6259","authenticated-orcid":false,"given":"Hideo","family":"Sasai","sequence":"additional","affiliation":[{"name":"Department of Early Diagnosis and Preventive Medicine for Rare Intractable Pediatric Diseases, Graduate School of Medicine, Gifu University, 1-1 Yanagido, Gifu 501-1194, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miori","family":"Yuasa","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Faculty of Medical Sciences, University of Fukui, 23-3 Matsuoka-Shimoaizuki, Eiheiji-cho 910-1193, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yosuke","family":"Shigematsu","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Faculty of Medical Sciences, University of Fukui, 23-3 Matsuoka-Shimoaizuki, Eiheiji-cho 910-1193, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4622-5657","authenticated-orcid":false,"given":"Satoshi","family":"Okada","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Hiroshima University Graduate School of Biomedical and Health Sciences, 1-2-3 Kasumi, Minami-ku, Hiroshima 734-8551, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2024,2,20]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/0925-4439(93)90058-9","article-title":"Very-long-chain acyl-CoA dehydrogenase deficiency: Identification of new inborn error of mitochondrial fatty acid oxidation in fibroblasts","volume":"1180","author":"Bertrand","year":"1993","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1006\/bbrc.1993.1368","article-title":"A novel disease with deficiency of mitochondrial very-long-chain acyl-CoA dehydrogenase","volume":"191","author":"Aoyama","year":"1993","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1203\/00006450-199307000-00025","article-title":"Identification of very-long-chain acyl-CoA dehydrogenase deficiency in three patients previously diagnosed with long-chain acyl-CoA dehydrogenase deficiency","volume":"34","author":"Yamaguchi","year":"1993","journal-title":"Pediatr. Res."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1086\/302261","article-title":"Clear correlation of genotype with disease phenotype in very-long-chain acyl-CoA dehydrogenase deficiency","volume":"64","author":"Andresen","year":"1999","journal-title":"Am. J. Hum. Genet."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/GIM.0b013e31820d5e67","article-title":"Clinical validation of cutoff target ranges in newborn screening of metabolic disorders by tandem mass spectrometry: A worldwide collaborative project","volume":"13","author":"McHugh","year":"2011","journal-title":"Genet. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s11154-018-9448-1","article-title":"Disorders of mitochondrial long-chain fatty acid oxidation and the carnitine shuttle","volume":"19","author":"Knottnerus","year":"2018","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1542\/peds.2006-0666","article-title":"Neonatal screening for very long-chain acyl-coA dehydrogenase deficiency: Enzymatic and molecular evaluation of neonates with elevated C14:1-carnitine levels","volume":"118","author":"Liebig","year":"2006","journal-title":"Pediatrics"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.jpeds.2010.04.063","article-title":"Tandem mass spectrometry screening for very long-chain acyl-CoA dehydrogenase deficiency: The value of second-tier enzyme testing","volume":"157","author":"Spiekerkoetter","year":"2010","journal-title":"J. Pediatr."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1007\/s10545-018-0245-5","article-title":"The diagnostic challenge in very-long chain acyl-CoA dehydrogenase deficiency (VLCADD)","volume":"41","author":"Hesse","year":"2018","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/8904_2015_476","article-title":"The newborn screening paradox: Sensitivity vs. overdiagnosis in VLCAD deficiency","volume":"27","author":"Diekman","year":"2015","journal-title":"JIMD Rep."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.ymgme.2014.01.009","article-title":"Infants suspected to have very-long chain acyl-CoA dehydrogenase deficiency from newborn screening","volume":"111","author":"Merritt","year":"2014","journal-title":"Mol. Genet. Metab."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/8904_2017_40","article-title":"Four years\u2019 experience in the diagnosis of very long-chain acyl-CoA dehydrogenase deficiency in infants detected in three Spanish newborn screening centers","volume":"39","author":"Merinero","year":"2018","journal-title":"JIMD Rep."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"811","DOI":"10.3389\/fgene.2019.00811","article-title":"New ratios for performance improvement for identifying acyl-CoA dehydrogenase deficiencies in expanded newborn screening: A retrospective study","volume":"10","author":"Wang","year":"2019","journal-title":"Front. Genet."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"100535","DOI":"10.1016\/j.ymgmr.2019.100535","article-title":"Serum C14:1\/ C12:1 ratio is a useful marker for differentiating affected patients with very long-chain acyl-CoA dehydrogenase deficiency from heterozygous carriers","volume":"21","author":"Yamada","year":"2019","journal-title":"Mol. Genet. Metab. Rep."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"648493","DOI":"10.3389\/fgene.2021.648493","article-title":"Very long-chain acyl-CoA dehydrogenase deficiency: High incidence of detected patients with expanded newborn screening program","volume":"12","author":"Remec","year":"2021","journal-title":"Front. Genet."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"101002","DOI":"10.1016\/j.ymgmr.2023.101002","article-title":"Biochemical and molecular characteristics among infants with abnormal newborn screen for very-long-chain acyl-CoA dehydrogenase deficiency: A single center experience","volume":"37","author":"Upadia","year":"2023","journal-title":"Mol. Genet. Metab. Rep."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s10038-018-0527-7","article-title":"Management and diagnosis of mitochondrial fatty acid oxidation disorders: Focus on very-long-chain acyl-CoA dehydrogenase deficiency","volume":"64","author":"Yamada","year":"2019","journal-title":"J. Hum. Genet."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.ymgme.2022.03.009","article-title":"The frequencies of very long-chain acyl-CoA dehydrogenase deficiency genetic variants in Japan have changed since the implementation of expanded newborn screening","volume":"136","author":"Osawa","year":"2022","journal-title":"Mol. Genet. Metab."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"100634","DOI":"10.1016\/j.ymgmr.2020.100634","article-title":"False positive cases of elevated tetradecenoyl carnitine in newborn mass screening showed significant loss of body weight","volume":"24","author":"Bo","year":"2020","journal-title":"Mol. Genet. Metab. Rep."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0378-4347(99)00111-5","article-title":"Modifications in electrospray tandem mass spectrometry for a neonatal-screening pilot study in Japan","volume":"731","author":"Shigematsu","year":"1999","journal-title":"J. Chromatogr. B Biomed. Sci. Appl."},{"key":"ref_21","first-page":"31","article-title":"Current status and future tasks of quality assurance in newborn screening","volume":"33","author":"Hanai","year":"2023","journal-title":"Jpn. J. Neonatal Screen."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1203\/PDR.0b013e318187cc44","article-title":"Development of a new enzymatic diagnosis method for very-long-chain acyl-CoA dehydrogenase deficiency by detecting 2-hexadecenoyl-CoA production and its application in tandem mass spectrometry-based selective screening and newborn screening in Japan","volume":"64","author":"Tajima","year":"2008","journal-title":"Pediatr. Res."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1212\/01.WNL.0000130486.54839.15","article-title":"A new diagnostic test for VLCAD deficiency using immunohistochemistry","volume":"62","author":"Ohashi","year":"2004","journal-title":"Neurology"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/s41439-020-0097-z","article-title":"Novel HADHB mutations in a patient with mitochondrial trifunctional protein deficiency","volume":"7","author":"Nakama","year":"2020","journal-title":"Hum. Genome Var."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1023\/A:1005504223140","article-title":"Disorders of fatty acyl-CoA \u03b2-oxidation","volume":"22","author":"Wanders","year":"1999","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ymgme.2005.12.012","article-title":"VLCAD deficiency: Pitfalls in newborn screening and confirmation of diagnosis by mutation analysis","volume":"88","author":"Boneh","year":"2006","journal-title":"Mol. Genet. Metab."},{"key":"ref_27","first-page":"310","article-title":"Analysis of ACADVL gene variations among nine neonates with very long-chain acyl-CoA dehydrogenase deficiency","volume":"36","author":"Tong","year":"2019","journal-title":"Zhonghua Yi Xue Chuan Xue Za Zhi"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"108","DOI":"10.17925\/EE.2021.17.2.108","article-title":"Diagnosis and clinical management of long-chain fatty-acid oxidation disorders: A review","volume":"17","author":"Baker","year":"2021","journal-title":"touchREVIEWS Endocrinol."}],"container-title":["International Journal of Neonatal Screening"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2409-515X\/10\/1\/15\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:01:52Z","timestamp":1760104912000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2409-515X\/10\/1\/15"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,20]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,3]]}},"alternative-id":["ijns10010015"],"URL":"https:\/\/doi.org\/10.3390\/ijns10010015","relation":{},"ISSN":["2409-515X"],"issn-type":[{"value":"2409-515X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,20]]}}}